In this virtual tumor board, David P. Steensma, MD, FACP, Reza Nejati, MD, and Ilene Galinsky, BSN, MSN, ANP-C, discuss patient and tumor characteristics that inform personalized care plans, risk stratification, and supportive care strategies for patients with MDS.

Join Jaffer A. Ajani, MD, for this live ASCO20 Virtual Ancillary Educational Event on May 31, 2020 at 5:00pm. Dr. Ajani will review emerging data on novel therapies for patients with metastatic disease. Learners will be able to engage in case studies via audience polling. Register now!

Join Judd W. Moul, MD, for this live ASCO20 Virtual Ancillary Educational Event on May 29, 2020 at 2:00pm. Dr. Moul will review emerging data on novel therapies for metastatic and nonmetastatic prostate cancer. Learners will be able to engage in case studies via audience polling. Register now!

Learn more about personalized care plans in advanced NSCLC with Mark A. Socinski, MD, Maureen F. Zakowski, MD and Victoria Sherry, DNP, CRNP, AOCNP^® as they discuss prognostic markers, current therapies, and adverse event management in this multidisciplinary virtual tumor board.

This case-based presentation developed by Arjun V. Balar, MD, discusses patient and tumor-related factors that can inform personalized care plans as well as novel therapies and adverse event management. Click to learn more and start the activity!

In this multidisciplinary discussion, James B. Bussel, MD & Allison Miller Imahiyerobo, APN explore ITP pathogenesis, current and emerging therapies, and supportive care strategies that help ITP patients achieve their goals of therapy. Register/Sign in to get started!

In this online activity, Srdan Verstovsek, MD, PhD, explores predictive and prognostic markers for personalized care planning in myelofibrosis as well as emerging data in therapeutic strategies and the implications that research advances may have for future practice.

Watch this case-based CME-approved recording with Jamie E. Chaft, MD, as she discusses molecular and clinical factors that can inform first- and second-line treatment strategies for patients with NSCLC.

In this case-based online activity, Miguel-Angel Perales, MD, discusses the graft-versus-leukemia effects of HSCT, emerging data on conditioning and maintenance therapies, and the management of transplant-related complications. Register today!

This online strategy session features a multidisciplinary discussion between Anthony R. Mato, MD, MSCE and Colleen Dorsey, RN, BSN as they discuss risk for TLS, signs and symptoms, as well as prevention and treatment strategies in patients with hematologic malignancies.